DexCom, Inc. Price Today
DexCom, Inc.
DXCM
Healthcare
$53.95B
💰
Market Cap
107.6
💸
Price to Earnings
$1.3
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
11 |
Strong Buy |
15 |
Hold |
4 |
Sell |
0 |
Strong Sell |
0 |
DXCM Price Forecast Target
139.9 👉 170.0 +21%
DXCM EPS Forecast
1.3 👉 2.2 +72%
Financials
Profit Margin
15 %
Revenue Growth
26.9 %
Dividend
$ 0
Held Percent
0.4% - Insiders
103.0% - Institutions
-3.4% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Seth Klarman Portfolio
Seth Klarman's investment prowess is exemplified by his exceptional track record. Since the inception of his fund until 2008, he achieved an impressive compound return-on-investment of 20%. This remarkable achievement showcases his astute investment…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Nancy Pelosi Portfolio
Nancy Pelosi is the Speaker of the United States House of Representatives and a savvy investor. Her personal portfolio is heavily weighted towards large-cap tech stocks, such as Apple and Microsoft. She also owns shares in several consumer staples a…📮FAQ
Some Frequently Asked Questions.
The DexCom, Inc. industry is Medical Devices
The DexCom, Inc. sector is Healthcare
The DexCom, Inc. forecasted predicted Price to Earnings PE ratio is 62.8
The DexCom, Inc. Price to Earnings PE ratio is 107.6
The Market Capitalization of DexCom, Inc. is $53.95B
There are total of 379663297 float shares with 103.0% held by Institutions and 0.4% held by insiders
The MDexCom, Inc. forecasted Earnings per Share EPS is $2.2
The DexCom, Inc. Earnings per Share EPS is 1.3
The DexCom, Inc. company has $0 gross profits with 15 profit margins
The DexCom, Inc. Earnings Growth is 1.81% with 1.792% quarterly earnings growth
The DexCom, Inc. Revenue is $3622299904 with 0.269 revenue growth
The price target for DexCom, Inc. stock is $170.0 for the high target and $122.0 for the low target
The consensus analyst recommendations for DexCom, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for DexCom, Inc. is Buy, with the following breakdown:
- Buy: 11
- Strong Buy: 15
- Hold: 4
- Sell: 0
- Strong Sell: 0
The Beta of DexCom, Inc. is 1.2
The dividend of DexCom, Inc. is $0
The dividend yield of DexCom, Inc. is 0%
The biggest institutional and mutual fund holders of DexCom, Inc. stock are
The DexCom, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0